Doctors Debate FDA Move, Which May Have Big Implications for Cancer Drug Approvals
The U.S. Food and Drug Administration Friday afternoon granted a conditional approval for Avastin to treat breast cancer patients -- despite a recommendation by an FDA expert advisory panel in December to reject the new use.
The FDA has traditionally approved drugs for late-stage cancer only if they extended or improved the quality of patients' lives. In this case, the agency's decision to approve Avastin was based on the drug's tumor-shrinking abilities.
Some experts say the basis of this... Full Story
Contribute | Do you have more information about this topic? If so, please click here to contact the editors of ABC News.
19 Comments | Add Yours
